Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy.
about
Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma.Dehydrocostus lactone, a natural sesquiterpene lactone, suppresses the biological characteristics of glioma, through inhibition of the NF-κB/COX-2 signaling pathway by targeting IKKβ.Development and Characterisation of a Novel NF-κB Reporter Cell Line for Investigation of Neuroinflammation.Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity.A tumor-suppressive microRNA, miRNA-485-5p, inhibits glioma cell proliferation and invasion by down-regulating TPD52L2.Pharmacological effects of asiatic acid in glioblastoma cells under hypoxia.High expression of Bruton's tyrosine kinase (BTK) is required for EGFR-induced NF-κB activation and predicts poor prognosis in human glioma.Culture on 3D Chitosan-Hyaluronic Acid Scaffolds Enhances Stem Cell Marker Expression and Drug Resistance in Human Glioblastoma Cancer Stem Cells.Molecular Determinants of Malignant Brain Cancers: From Intracellular Alterations to Invasion Mediated by Extracellular Vesicles.The ten-year evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusion.Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway.Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic.NF-κB Signalling in Glioblastoma.Unlocking the NF-κB Conundrum: Embracing Complexity to Achieve Specificity.Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways.Amentoflavone Induces Apoptosis and Inhibits NF-ĸB-modulated Anti-apoptotic Signaling in Glioblastoma Cells.Combined c-Met/Trk inhibition overcomes resistance to CDK4/6 inhibitors in Glioblastoma.Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells.Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas.Re-purposing Chloroquine for Glioblastoma: Potential Merits and Confounding VariablesNF-κB, Mesenchymal Differentiation and Glioblastoma
P2860
Q33779029-E094D241-C09C-4DC3-935D-26D1F44AC658Q33850038-D41555D7-8C2C-4458-894F-BEEDA5992414Q38695402-4E34C439-28CA-4434-84E7-49025B006E6CQ40116157-9495B574-7505-4AEE-871D-9854C65414BAQ41364290-40A5F474-2BC7-4444-A36F-E28C63B8724CQ42029615-15BB89A3-F03A-4A2A-81A3-34AC7E14EE54Q42363894-361F3821-9E1A-44AC-BC98-8E99A3C8C78DQ45893116-BD91D043-09EF-4599-B478-3DC961ABCC17Q47183915-EA5D6CED-A643-4E35-8081-07815D345400Q47853157-3BE75539-99F5-427D-817C-C943EDFD83E2Q50148579-43A0E21C-0136-4E85-9BAF-28141C3CA97AQ51825149-CA147A3B-BE79-48CC-B5F6-DD0522C7C12BQ52091959-67E0CA06-DDE8-4C44-8E87-A56689E8A0F3Q52538370-58686D0D-B2F5-487E-901E-A05DFC4C6BFDQ52590668-C4A7216A-0699-4B47-A476-2D1BEF729E81Q52730709-FB5119EF-048C-4894-A7F9-E22CA4A142F6Q54977810-35BCFE77-E038-4BB3-B222-72C9601BB0D4Q55379488-921FE851-388D-4412-BEEC-A65B9A886949Q55457391-68D19416-69C1-4818-A327-6EBB19377FAAQ58700712-6A25A070-9BB4-4440-BD3F-B62C3ABB237EQ58779206-66553B0E-DF9A-4FE5-9A88-F3A836F31C8D
P2860
Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy.
@en
type
label
Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy.
@en
prefLabel
Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy.
@en
P2093
P2860
P356
P1433
P1476
Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy.
@en
P2093
Bakhtiar Yamini
Kirk E Cahill
Ramin A Morshed
P2860
P304
P356
10.1093/NEUONC/NOV265
P577
2015-11-02T00:00:00Z